Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

NCT00000904 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: ALVAC(2)120(B,MN)GNP (vCP1452)
BIOLOGICAL: gp160 MN/LAI-2
BIOLOGICAL: ALVAC(1)120(B,MN)GNP (vCP1433)
BIOLOGICAL: ALVAC-HIV MN120TMG (vCP205)
BIOLOGICAL: ALVAC-RG Rabies Glycoprotein (vCP65)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)